FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

P Mommen

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Phenomena

Karnofsky Performance Status

Co-author Network

Publications

TOP 3
Thierry Berghmans; Jean-Jacques Lafitte; Marianne Paesmans; B Stach; MC Berchier; P Wackenier; J Lecomte; T Collon; P Mommen; Jean-Paul Sculier
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Thierry Berghmans; Jean-Jacques Lafitte; J Thiriaux; P VanHoutte; J Lecomte; Anna P Efremidis; George Koumakis; V Giner; M Richez; J L Corhay; P Wackenier; P Lothaire; P Mommen; Vincent Ninane; Jean-Paul Sculier
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Jean-Paul Sculier; Jean-Jacques Lafitte; Thierry Berghmans; P van Houtte; J Lecomte; J Thiriaux; Anna P Efremidis; George Koumakis; V Giner; M Richez; J-L Corhay; P Wackenier; P Lothaire; Marianne Paesmans; P Mommen; Vincent Ninane
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of P Mommen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Thierry Berghmans; Jean-Jacques Lafitte; Marianne Paesmans; B Stach; MC Berchier; P Wackenier; J Lecomte; T Collon; P Mommen; Jean-Paul Sculier
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):75-82.
2004: Thierry Berghmans; Jean-Jacques Lafitte; J Thiriaux; P VanHoutte; J Lecomte; Anna P Efremidis; George Koumakis; V Giner; M Richez; J L Corhay; P Wackenier; P Lothaire; P Mommen; Vincent Ninane; Jean-Paul Sculier
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Lung cancer (Amsterdam, Netherlands) 2004;45(3):339-48.
2004: Jean-Paul Sculier; Jean-Jacques Lafitte; Thierry Berghmans; P van Houtte; J Lecomte; J Thiriaux; Anna P Efremidis; George Koumakis; V Giner; M Richez; J-L Corhay; P Wackenier; P Lothaire; Marianne Paesmans; P Mommen; Vincent Ninane
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):399-409.
2002: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; Thierry Berghmans; J Thiriaux; O Van Cutsem; Anna P Efremidis; Vincent Ninane; Marianne Paesmans; P Mommen; Jean Klastersky
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1454-9.
2002: Jean-Paul Sculier; Thierry Berghmans; Jean-Jacques Lafitte; M Richez; P Recloux; O Van Cutsem; Vincent Ninane; P Mommen; Marianne Paesmans; Jean Klastersky
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):73-7.
2002: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; Thierry Berghmans; J Thiriaux; MC Florin; Anna P Efremidis; CG Alexopoulos; P Recloux; Vincent Ninane; P Mommen; Marianne Paesmans; Jean Klastersky
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):874-82.
2001: Jean-Paul Sculier; Marianne Paesmans; J Lecomte; O Van Cutsem; Jean-Jacques Lafitte; Thierry Berghmans; George Koumakis; MC Florin; J Thiriaux; J Michel; V Giner; MC Berchier; P Mommen; Vincent Ninane; Jean Klastersky
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
British journal of cancer 2001;85(10):1444-51.
2000: Jean-Paul Sculier; Jean-Jacques Lafitte; Marianne Paesmans; J Thiriaux; CG Alexopoulos; J Baumöhl; J Schmerber; George Koumakis; MC Florin; Constantinos Zacharias; Thierry Berghmans; P Mommen; Vincent Ninane; Jean Klastersky
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
British journal of cancer 2000;83(9):1128-35.
2000: Marianne Paesmans; Jean-Paul Sculier; J Lecomte; J Thiriaux; P Libert; R Sergysels; G Bureau; G Dabouis; O Van Cutsem; P Mommen; Vincent Ninane; Jean Klastersky
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Cancer 2000;89(3):523-33.
2000: Jean-Paul Sculier; Jean-Jacques Lafitte; Thierry Berghmans; J Thiriaux; J Lecomte; Anna P Efremidis; Vincent Ninane; Marianne Paesmans; P Mommen; Jean Klastersky
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com.
Lung cancer (Amsterdam, Netherlands) 2000;29(1):67-73.
1999: Thierry Berghmans; Jean Klastersky; Eveline Markiewicz; P Mommen; Jean-Paul Sculier
Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studies.
Anticancer research 1999;19(6C):5651-5.
1999: Jean-Paul Sculier; Marianne Paesmans; J Thiriaux; J Lecomte; G Bureau; V Giner; George Koumakis; Jean-Jacques Lafitte; MC Berchier; CG Alexopoulos; Constantinos Zacharias; P Mommen; Vincent Ninane; Jean Klastersky
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1314-9.
1999: Jean-Paul Sculier; Marianne Paesmans; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; G Bureau; MC Berchier; Constantinos Zacharias; P Mommen; T Bosschaerts; Thierry Berghmans; P van Houtte; Vincent Ninane; Jean Klastersky
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):295-303.
1998: Jean-Paul Sculier; Marianne Paesmans; Vincent Ninane; V Giner; G Bureau; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; MC Berchier; Constantinos Zacharias; P Mommen; P van Houtte; Jean Klastersky
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Lung cancer (Amsterdam, Netherlands) 1998;22(3):201-13.
1998: Jean-Paul Sculier; Marianne Paesmans; J Thiriaux; J Lecomte; G Bureau; V Giner; Anna P Efremidis; Jean-Jacques Lafitte; MC Berchier; CG Alexopoulos; Constantinos Zacharias; P Mommen; Vincent Ninane; Jean Klastersky
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1388-96.
1997: Marianne Paesmans; Jean-Paul Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen; Jean Klastersky
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2326-32.
1997: Jean-Paul Sculier; Marianne Paesmans; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; P Mommen; R Sergysels; Jean Klastersky
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
Revue des maladies respiratoires 1997;14(6):445-9.
1996: M Borges; Jean-Paul Sculier; Marianne Paesmans; M Richez; G Bureau; G Dabouis; J Lecomte; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; R Sergysels; P Mommen; Jean Klastersky
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Lung cancer (Amsterdam, Netherlands) 1996;16(1):21-33.
1996: Jean-Paul Sculier; Marianne Paesmans; G Bureau; V Giner; J Lecomte; J Michel; MC Berchier; O Van Cutsem; U Küstner; F Kroll; R Sergysels; P Mommen; Jean Klastersky
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2337-44.
1995: Marianne Paesmans; Jean-Paul Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1221-30.
1995: Jean-Paul Sculier; G Bureau; V Giner; J Thiriaux; J Michel; MC Berchier; O Van Cutsem; U Küstner; F Kroll; P Mommen
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Seminars in oncology 1995;22(1 Suppl 2):18-22.
1989: J J Body; J C Dumon; J P Sculier; G Dabouis; H Lacroix; P Libert; M Richez; G Bureau; P Mommen; N Raymakers
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
Henry Ford Hospital medical journal 1989;37(3-4):190-3.
1988: P van Houtte; Jean Klastersky; A Renaud; J Michel; G Vandermoten; H Nguyen; Jean-Paul Sculier; J Devriendt; P Mommen
Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
Antibiotics and chemotherapy 1988;41():131-7.
1986: Jean-Paul Sculier; Jean Klastersky; J P Dumont; G Vandermoten; P Rocmans; P Libert; P Ravez; D Becquart; P Mommen; O Dalesio
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
Cancer treatment reports 1986;70(6):773-5.